FDA Approves Sun Pharma’s Benzonatate Capsules
March 24, 2008
Sun Pharmaceutical Industries has announced that the FDA has granted approval for the abbreviated new drug application to market benzonatate capsules.
Benzonatate USP capsules are therapeutically equivalent to Forest Lab’s Tessalon, and are available in two strengths: capsules containing 100mg and 200mg benzonatate USP.
Benzonatate is an antitussive, used to relieve cough due to the common cold, bronchitis, pneumonia, or other lung infections. This product will reach market shortly.